Insys Therapeutics, Inc. (INSY)

4.21
NASDAQ
Prev Close 4.21
Day Low/High 0.00 / 0.00
52 Wk Low/High 3.35 / 11.65
Exchange NASDAQ
Shares Outstanding 74.43B
Market Cap 313.34M
Div & Yield N.A. (N.A)

Latest News

FDA Approval Puts GW Pharma, Three Other Cannabis-Related Names in the Spotlight

FDA Approval Puts GW Pharma, Three Other Cannabis-Related Names in the Spotlight

The milestone approval of Epidiolex bodes well for cannabis-based drug stocks GW Pharma, Nemus, Zynerba and Insys.

Seven U.S. Stocks Offering Cannabis Exposure

Seven U.S. Stocks Offering Cannabis Exposure

While cannabis remains illegal on a federal level, these seven names are making early inroads into the growing industry.

Abeona Shares Higher After Pricing Stock Offering -- Biotech Movers

Abeona Shares Higher After Pricing Stock Offering -- Biotech Movers

The clinical-stage biopharmaceutical firm said Oct. 16 it has priced an underwritten public offering of five million shares at $16 apiece.

Three Pot Stocks to Watch for 2017

Three Pot Stocks to Watch for 2017

Donald Trump was not the only big winner on Election Day. The cannabis industry got a spark as well.

Stocks With Earnings Revised Up

This trend is a good indication that business is going well.

Organic IPOs: BioAmber, Insys

Organic IPOs: BioAmber, Insys

From green technology to medicinal marijuana, investors will be surprised at which IPO looks good. Francis Gaskins gives details.